Trial Optimization & FDA Risk Reduction
Design smarter from Day 1. Telperian helps you simulate trial scenarios, reduce risk, and accelerate readiness—while staying aligned with FDA expectations.
Why It Matters
Today’s trials face tighter budgets, faster timelines, and evolving FDA guidance. Telperian enables sponsors to explore “what-if” scenarios early, reduce avoidable amendments, and approach regulators with confidence.
How We Help
Simulate different design options before protocol finalization
Evaluate key operating characteristics like interim analysis thresholds
Prepare statistical outputs and visualizations for early FDA conversations
Align With the New FDA Norm
Whether you’re navigating Project Optimus, Frontrunner, or adaptive design pathways, Telperian supports you in designing defensible, data-informed protocols from the start.
Results That Matter
Fewer Amendments
Avoid downstream redesigns
Faster Readiness
Streamline protocol development
Smarter Decisions
Engage regulators with
evidence-backed models
Built for Oncology, Designed for Speed
Our approach is trusted by biostatistics leads and trial strategists in oncology and high-impact therapeutic areas.
Let’s Design
Better, Together
Whether you’re preparing your first-in-human trial or planning a pivotal Phase II/III, we’re here to help.
